Items where Author is "Hadjati, J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Namdar, A. and Mirzaei, R. and Memarnejadian, A. and Boghosian, R. and Samadi, M. and Mirzaei, H.R. and Farajifard, H. and Zavar, M. and Azadmanesh, K. and Elahi, S. and Noorbakhsh, F. and Rezaei, A. and Hadjati, J. (2018) Prophylactic DNA vaccine targeting Foxp3 + regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model. Cancer Immunology, Immunotherapy, 67 (3). pp. 367-379.

Namdar, A. and Mirzaei, R. and Memarnejadian, A. and Boghosian, R. and Samadi, M. and Mirzaei, H.R. and Farajifard, H. and Zavar, M. and Azadmanesh, K. and Elahi, S. and Noorbakhsh, F. and Rezaei, A. and Hadjati, J. (2018) Prophylactic DNA vaccine targeting Foxp3+regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model. Cancer Immunology, Immunotherapy, 67 (3). pp. 367-379.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H.R. and Jaafari, M.R. and Riahi, M.M. and Ebrahimnejad, H. and Nahand, J.S. and Hadjati, J. and Asrami, M.O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

This list was generated on Mon Apr 22 22:48:58 2019 EDT.